Cancer BiologybioRxivPreprint
Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids
Y. Li, T. Dismuke, C. Lim…·B. W. Day
This study shows that targeting OLIG2 with CT-179 reduces recurrence in SHH medulloblastoma models and improves survival when combined with radiotherapy.
DOI 10.1101/2022.02.14.480293